MALAT1 and neoplasm: Consistent with the results of IKE treatment, HBX overexpression also significantly attenuated the inhibitory effect of Erastin on tumor growth, leading to increased tumor volume and weight, while MALAT1 re-expression effectively rescued these inhibitory effects (Figure S12A-E).